CoQ10 Researh References:
Allen KL et al. Changes
of respiratory chain activity in mitochondrial and synaptosomal
fractions isolated from the gerbil brain after graded ischaemia. 1995.
J Neurochem 64: 2222-2229.
Ankarcrona M et al. Glutamate-induced neuronal death: a succession of
necrosis or apoptosis depending on mitochondrial function. 1995.
Neuron 15: 961-973.
Barbiroli B et al. Coenzyme Q10 improves mitochondrial respiration in
patients with mitochondrial cytopathies. An in vivo study on brain and
skeletal muscle by phosphorous magnetic resonance spectroscopy. 1997.
Cell Molec Biol 43: 741-749.
Beal MF. Aging, energy, and oxidative stress in neurodegenerative
diseases. 1995. Ann Neurol 38:
357-366.
Beal MF et al. Coenzyme Q10 and nicotinamide block striatal lesions
produced by the mitochondrial toxin malonate. 1994.
Ann Neurol 36: 882-888.
Beal MF et al. Coenzyme Q10 atenuates the
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced loss of
striatal dopamine and dopaminergic axons in aged mice. 1998.
Brain Res 783: 109-114.
Bendahan D et al. P NMR spectroscopy and ergometer exercise test as
evidence for muscle oxidative performance improvement with coenzyme Q in
mitochondrial myopathies. 1992. Neurology
42: 1203-1208.
Bolanos JP et al. Nitric oxide-mediated mitochondrial damage in the
brain: mechanisms and implications for neurodegenerative diseases. 1997.
J Neurochem 68: 2227-2240.
Bonilla E et al. Mitochondrial involvement in Alzheimer’s disease. 1999.
Biochim Biophys Acta 1410: 171-182.
Bozner P et al. The amyloid b protein induces oxidative damage of
mitochondrial DNA. 1997. J Neuropathol Exp
Neurol 56: 1356-1362.
Bresolin N et al. Ubidecarenone in the treatment of mitochondrial
myopathies: a multi-center double-blind trial. 1990.
J Neurol Sci 100: 70-78.
Brookes PS et al. Peroxynitrite and brain mitochondria: evidence for
increased proton leak. 1998. J Neurochem
70: 2195-2202.
Brown AM et al. Correlation of the clinical severity of Alzheimer’s
disease with an aberration in mitochondrial DNA (mtDNA). 2001.
J Mol Neurosci 16: 41-8.
Cassarino DS et al. An evaluation of the role of mitochondria in
neurodegenerative diseases: mitochondrial mutations and oxidative
pathology, protective nuclear responses, and cell death in
neurodegeneration. 1999. Brain Res
Rev 29: 1-25.
Ebadi M et al. Ubiquinone (coenzyme q10) and mitochondria in oxidative
stress of parkinson’s disease. 2001. Biol
Signals Recept 10: 224-53.
Favit A et al. Ubiquinone protects cultured neurons against spontaneous
and excitotoxin-induced degeneration. 1992.
J Cereb Blood Flow Metab 12: 638-645.
Fiskum G et al. Mitochondria in neurodegeneration: acute ischemia and
chronic neurodegenerative diseases. 1999. J
Cereb Blood Flow Metab 19: 351-369.
Floyd RA. Neuroinflammatory processes are important in neurodegenerative
diseases: an hypothesis to explain the increased formation of reactive
oxygen species and nitrogen species as major factors involved in
neurodegenerative disease development. 1999.
Free Radic Biol Med 26: 1346-1355.
Folkers K et al. Two successful double-blind trials with coenzyme Q10
(vitamin Q10) on muscular dystrophies and neurogenic atrophies. 1995.
Biochim Biophys Acta 1271: 281-286.
Gabuzda D et al. Inhibition of energy metabolism alters the processing
of amyloid precursor protein and induces a potentially amyloidogenic
derivative. 1994. J Biol Chem 269:
13623-13628.
Grieb P et al. Oral coenzyme Q10 administration prevents the development
of ischemic brain lesions in a rabbit model of symptomatic vasospasm.
1997. Acta Neuropathol 94: 363-368.
Harman D. A hypothesis on the pathogenesis of Alzheimer’s disease. 1996.
Ann NY Acad Sci 786: 152-168.
Koroshetz WJ et al. Energy metabolism defects in Huntington’s disease
and effects of Coenzyme Q10. 1997. Ann
Neurol 41: 160-165.
Kuroda S et al. Reperfusion damage following focal ischemia:
pathophysiology and therapeutic windows. 1997.
Clin Neurosci 4: 199-212.
Leist M et al. Apoptosis, excitotoxicity, and neuropathology. 1998.
Exp Cell Res 239: 183-201.
Lodi R et al. Antioxidant treatment improves in vivo cardiac and
skeletal muscle bioenergetics in patients with Friedreich’s ataxia.
2001. Ann Neurol 49: 590-6.
Lonnrot K et al. Control of arterial tone after long-term coenzyme Q10
supplementation in senescent rats. 1998.
Brit J Pharmacol 124: 1500-1506.
Love S. Oxidative stress in brain ischemia. 1999.
Brain Pathol 9: 119-131.
Mariani C et al. Muscle biopsy in Alzheimer’s disease: morphological and
biochemical findings. 1991. Clin Neuropathol
10: 171-176.
Mark RJ et al. A role for 4-hydroxynonenal, an aldehydic product of
lipid peroxidation, in disruption of ion homeostasis and neuronal death
induced by amyloid b-peptide. 1997. J
Neurochem 68: 255-264.
Mark RJ et al. Amyloid b-peptide impairs glucose transport in
hippocampal and cortical neurons: involvement of membrane lipid
peroxidation. 1997. J Neurosci 17:
1046-1054.
Markesbery WR. Oxidative stress hypothesis in Alzheimer’s disease. 1997.
Free Radic Biol Med 23: 134-147.
Markesbery WR. Oxidative alterations in Alzheimer’s disease. 1999.
Brain Pathol 9: 133-146.
Matsumoto S et a. Blockade of the mitochondrial permeability transition
pore diminishes infarct size in the rat after transient middle cerebral
artery occlusion. 1999. J Cereb Blood Flow
Metab 19: 736-741.
Matthews RT et al. Coenzyme Q10 administration increases brain
mitochondrial concentrations and exerts neuroprotective effects. 1998.
Proc Natl Acad Sci USA 95: 8892-8897.
Mazzio E et al. Effect of antioxidants on L-glutamate and
N-methyl-4-phenylpyridinium ion induced-neurotoxicity in PC12 cells.
2001. Neurotoxicology 22: 283-8.
Mecocci P et al. Oxidative damage to mitochondrial DNA shows marked
age-dependent increases in human brain. 1993.
Ann Neurol 34: 609-616.
Mizuno Y et al. Mitochondrial dysfunction in Parkinson’s disease. 1998.
Ann Neurol 44, Suppl 1: S99-S109.
Mordente A et al. Free radical production by activated haem proteins:
protective effect of coenzyme Q. 1994. Molec
Aspects Med. 15, Suppl: S109-S115.
Munch G et al. Alzheimer’s disease - synergistic effects of glucose
deficit, oxidative stress and advanced glycation endproducts. 1998.
J Neural Transm 105: 439-461.
Murphy AN et al. Mitochondria in neurodegeneration: bioenergetic
function in cell life and death. 1999. J
Cereb Blood Flow Metab 19: 231-245.
Musumeci O et al. Familial cerebellar ataxia with muscle coenzyme Q10
deficiency. 2001. Neurology 56:
849-55.
Nicotera P et al. Neuronal cell death: a demise with different shapes.
1999. Trends Pharmacol Sci 20: 46-51.
Novelli A et al. Glutamate becomes neurotoxic via the N-methyl-D-aspartate
receptor when intracellular energy levels are reduced. 1988.
Brain Res 451: 205-212.
Ogawa N et al. Survival effect of coenzyme Q10 and naloxone on
experimental stroke gerbils. 1986. Pharmacol
Biochem Behav 24: 315-317.
Ristow M et al. Frataxin activates mitochondrial energy conversion and
oxidative phosphorylation. 2000. Proc Natl
Acad Sci U S A. 97: 12239-43.
Sharman EH et al. Effects of age and dietary antioxidants on cerebral
electron transport chain activity. 2001.
Neurobiol Aging 22: 629-34.
Shults CW et al. Coenzyme Q10 levels correlate with the activities of
complexes I and II/III in mitochondria from parkinsonian and
nonparkinsonian subjects. 1997. Ann Neurol
42: 261-264.
Shults CW et al. Absorption, tolerability, and effects on mitochondrial
activity of oral coenzymeQ10 in parkinsonian patients. 1998.
Neurology 50: 793-5.
Schulz JB et al. Neuroprotective strategies for treatment of lesions
produced by mitochondrial toxins: implications for neurodegenerative
diseases. 1996. Neuroscience 71:
1043-1048.
Smith MA et al. Widespread peroxynitrite-mediated damage in Alzheimer’s
disease. 1997. J Neurosci 17:
2653-2657.
Sobreira C et al. Mitochondrial encephalomyopathy with coenzyme Q10
deficiency. 1997. Neurology 48:
1238-1243.
Tatton WG et al. Mitochondria in neurodegenerative apoptosis: an
opportunity for therapy? 1998. Ann Neurol
44, Suppl 1: S134-S141.
Tatton WG et al. Apoptosis in neurodegenerative diseases: the role of
mitochondria. 1999. Biochim Biophys Acta
1410: 195-213.
Turner C et al. Mitochondrial dysfunction in neurodegenerative disorders
and ageing. 2001. Adv Exp Med Biol
487: 229-51.
Veitch K et al. Global ischemia induces a biphasic response of the
mitochondrial respiratory chain. 1992.
Biochem J 281: 709-715.
Volpe M et al. Abnormalities of endothelial function in the pathogenesis
of stroke: the importance of endothelin. 2000.
J Cardiovasc Pharmacol 35, Suppl 2:
S45-48.
Webster MT et al. The effects of perturbed energy metabolism on the
processing of amyloid precursor protein in PC12 cells. 1998.
J Neural Transm 105: 839-853.
Weyer G et al. A controlled study of 2 doses of idebenone in the
treatment of Alzheimer’s disease. 1997.
Neuropsychobiology 36: 73-82.
Ying W. Deleterious network: a testable pathogenetic concept of
Alzheimer’s disease. 1997. Gerontology
43: 242-253.
Zeng Z et al. Mitochondrial DNA deletions are associated with ischemia
and aging in Balb/c mouse brain. 1999. J
Cell Biochem 73: 545-553.
back to top
|
